Pfizer has announced that its COVID-19 vaccine will be available for supply to community pharmacies and private healthcare providers from March 2024. Until now, COVID-19 vaccines in the UK have only been available through the NHS national immunisation programme (NIP). The Medicines and Health...
A Multi-Pronged Approach to COVID-19 Explore how vaccinations and treatment with oral medication for those eligible are working to combat COVID-19. Learn More Now Making & Distributing Our Vaccine Pfizer consistently and diligently monitors the supply of our medicines. ...
Get COVID-19 Vaccine Text Updates Enroll in the BioNTech & Pfizer COVID Connect text messaging program for U.S. Healthcare Professionals. Sign Up Call a Pfizer Connect Representative Live representatives available 9 AM–5 PM ET to help HCPs answer product questions, discuss Pfizer Prime orderin...
The FDA-approved COMIRNATY (COVID-19 Vaccine, mRNA) and the EUA-authorized Pfizer-BioNTech COVID-19 Vaccine for individuals 12 years of age and older when prepared according to their respective instructions for use can be used interchangeably.2 COMIRNATY (COVID-19 Vaccine, mRNA) and the ...
"The U.S. FDA set a threshold of 50% effectiveness for a Covid-19 vaccine to merit approval. A 90% effective vaccine would be extraordinary," Dr. Peter Drobac, a global health physician and director of the Skoll Centre for Social Entrepreneurship at the University of Oxford,...
The Studies We are proud to be part of developing the world's first COVID-19 vaccine, which has protected millions globally from this devastating disease. But our work is not done. Fighting COVID-19 requires adjustments to the vaccine to address new variants and provide ongoing protection. We...
Matthias Theobald, a fellow oncology professor at Mainz university who has worked with Sahin for 20 years, said his tendency towards understatement belies a relentless ambition to transform medicine, exemplified by the leap of faith to a COVID-19 vaccine. ...
Korea’s Ministry of Food and Drug Safety (MFDS) said Friday that it has granted approval for Pfizer Korea and BioNTech’s Comirnaty injection (tozinameran), a vaccine specifically tailored to combat the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage. ...
[01:53.08]Researchers said the vaccine was nearly 91 percent effective. [01:58.68]They found 16 COVID-19 cases among children [02:03.08]receiving the placebo and three cases [02:06.48]in children who received the actual ...
In its analysis of Pfizer's data, the FDA said that rates of hospitalization and death due to COVID-19 among children under 5 were higher than among those aged 5 to 17, "underscoring the benefit of an effective COVID-19 vaccine in this age group." ...